We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Enabling Accurate Mutation Analysis of FFPE Samples

Tumor App Note Snippet

Targeted sequencing based on NGS offers new perspectives in drug selection for cancer patients. The accuracy of mutation analysis relies on the tumor content of the tissue samples.

Download the recent application note by Dr. Hatakeyama et al. (Shizuoka Cancer Center, Japan) and learn more about:

  • How to improve the accuracy of mutation detection in FFPE tissue sections of gastric cancers
  • How our FFPE Tissue Dissociation Kit, together with the gentleMACS™ Technology, enables the preparation of single-cell suspensions to separate tumor cells from healthy cells
  • How this helps to increase the sequencing sensitivity for FFPE samples

Brought to you by
Download this App Note for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.